Proactive Investors - Run By Investors For Investors

Amphion Innovations trims its stake in Motif Bio

Life sciences and technology incubator Amphion Innovations recently rolled over £6.56mln of promissory notes due in December 2018 for a year.
US dollars
One-third of the proceeds from the sale will be retained for working capital

Amphion Innovations PLC (LON:AMP) has reduced its stake in partner company Motif Bio PLC (LON:MTFB, NASDAQ:MTFB) to 7.88%.

It sold 1.83mln shares in Motif, generating US$144,000, two-thirds of which will go to effect partial repayment of the loan facility it took out in mid-2014.

READ: Motif Bio to manage cash aggressively after making loan repayment

Prior to the sale, Amphion’s stake in Motif Bio, which is developing iclaprim, a next-generation antibiotic, was 8.51%.


View full AMP profile View Profile

Amphion Innovations PLC Timeline

Related Articles

May 15 2019
The company’s products can be used for wireless and mobile internet applications, while its military hardware encompasses a range of tactical and specialised communications antennas
Internet of things
March 01 2019
In an update in January, the company said that revenue for the year just ended would be at the top end of its guidance range at around US$427mln
Keywords Studio
April 08 2019
Keywords has a buy-and-build strategy and has been expanding rapidly since its first acquisition in 2014.

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use